Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inecalcitol + Decitabine in AML (unfit for chemo)
NCT02802267Phase 2Unknown
- Sponsor
- Hybrigenics
- Start
- Jun 2016
- Primary completion
- Dec 2018
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of inecalcitol in acute myeloid leukemia (AML), sponsored by Hybrigenics. Status: unknown.
02
Drugs
inecalcitol
03
Conditions
acute myeloid leukemia (AML)
Beyond the preview
Go deeper on NCT02802267.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02802267.